543 related articles for article (PubMed ID: 27339401)
41. Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre?
Jones A; Fergus JN; Chapman J; Houghton L
BJU Int; 1999 Jul; 84(1):79-84. PubMed ID: 10444129
[TBL] [Abstract][Full Text] [Related]
42. Management of testicular cancer--16 years' experience from southwest Finland.
Sundström J; Salminen E; Nurmi M; Toppari J; Pöllänen P; Pelliniemi LJ; Huhtala S; Rajala P; Laato M
Scand J Urol Nephrol; 2001 Feb; 35(1):21-5. PubMed ID: 11291682
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant radiotherapy for Stage I seminoma: A Single-institutional experience.
Kanyilmaz G; Saricanbaz I; Bora H; Karahacioglu E; Erkal EY
J Cancer Res Ther; 2019 Mar; 15(Supplement):S87-S90. PubMed ID: 30900627
[TBL] [Abstract][Full Text] [Related]
44. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
45. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
46. Management of stage II seminoma.
Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
[TBL] [Abstract][Full Text] [Related]
47. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
[TBL] [Abstract][Full Text] [Related]
48. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
49. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
[TBL] [Abstract][Full Text] [Related]
50. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
51. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
52. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
53. Late relapse of stage i seminoma following single-agent carboplatin.
Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
[TBL] [Abstract][Full Text] [Related]
54. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
Melchior D; Hammer P; Fimmers R; Schüller H; Albers P
Anticancer Res; 2001; 21(4B):2989-93. PubMed ID: 11712799
[TBL] [Abstract][Full Text] [Related]
55. Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan.
Khader J; Salem A; Abuodeh Y; Almousa A; Farah N; Abdelrahman F
BMC Urol; 2012 Apr; 12():10. PubMed ID: 22531005
[TBL] [Abstract][Full Text] [Related]
56. Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients.
Vallis KA; Howard GC; Duncan W; Cornbleet MA; Kerr GR
Br J Radiol; 1995 Apr; 68(808):400-5. PubMed ID: 7795977
[TBL] [Abstract][Full Text] [Related]
57. [Experience of the treatment for clinical Stage-1 seminoma over a period of 10 years].
Zhang XQ; Liu ZW; Zhou FJ; Han H; Qin ZK; Ye YL; Li YH; Hou GL; Zhang ZL
Chin J Cancer; 2010 Jan; 29(1):98-101. PubMed ID: 20038319
[TBL] [Abstract][Full Text] [Related]
58. Treatment Trends for Stage I Testicular Seminoma in an Equal-Access Medical System.
Wingate JT; Etzioni R; Macdonald DM; Brand TC
Clin Genitourin Cancer; 2016 Oct; 14(5):438-443. PubMed ID: 26794393
[TBL] [Abstract][Full Text] [Related]
59. Stage I seminoma of the testis: long term results and toxicity with adjuvant radiotherapy.
Amichetti M; Fellin G; Bolner A; Busana L; Pani G; Romano M; Scillieri M; Maluta S
Tumori; 1994 Apr; 80(2):141-5. PubMed ID: 8016907
[TBL] [Abstract][Full Text] [Related]
60. Surveillance in stage I seminoma patients: a long-term assessment.
Cummins S; Yau T; Huddart R; Dearnaley D; Horwich A
Eur Urol; 2010 Apr; 57(4):673-8. PubMed ID: 19545941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
